Literature DB >> 15306992

Health-economic consequences of diabetic foot lesions.

Gunnel Ragnarson Tennvall1, Jan Apelqvist.   

Abstract

Diabetic foot complications result in huge costs for both society and the individual patients. Few reports on the health-economic consequences of diabetic foot infections have been published. In studies considering a wide societal perspective, costs of antibiotics were relatively low, whereas total costs for topical treatment were high relative to the total costs of foot infections. Total direct costs for healing of infected ulcers not requiring amputation are approximately 17,500 dollars (in 1998 US dollars), whereas the costs for lower-extremity amputations are approximately 30,000 dollars-33,500 dollars depending on the level of amputation. Prevention of foot ulcers and amputations by various methods, including patient education, proper footwear, and foot care, in patients at risk is cost effective or even cost saving. Awareness of the potential influence of reimbursement systems on prevention, management, and outcomes of diabetic foot lesions has increased. Despite methodological obstacles, modeling studies are needed in future health-economic evaluations to determine the cost effectiveness of various strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15306992     DOI: 10.1086/383275

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  52 in total

1.  Prevalence and healthcare costs associated with the management of diabetic foot ulcer in patients attending Ahmadu Bello University Teaching Hospital, Nigeria.

Authors:  Umar Mukhtar Danmusa; Iorliam Terhile; Idris Abdullahi Nasir; Auwal Alkasim Ahmad; Habiba Yahaya Muhammad
Journal:  Int J Health Sci (Qassim)       Date:  2016-04

2.  Clinical Evaluation of a Novel Topical Negative Pressure Device in Promoting Healing in Chronic Wounds.

Authors:  Sarah Bradbury; Neal Walkley; Nicola Ivins; Keith Harding
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

3.  Etiology of Above-knee Amputations in the United States: Is Periprosthetic Joint Infection an Emerging Cause?

Authors:  Jaiben George; Suparna M Navale; Emmanuel M Nageeb; Gannon L Curtis; Alison K Klika; Wael K Barsoum; Michael A Mont; Carlos A Higuera
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

Review 4.  Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: diabetic foot ulcer.

Authors:  Akinfemi Ayobami Akingboye; Stephen Giddins; Philip Gamston; Arthur Tucker; Harshad Navsaria; Constantions Kyriakides
Journal:  J Extra Corpor Technol       Date:  2010-03

Review 5.  Literature review on the management of diabetic foot ulcer.

Authors:  Leila Yazdanpanah; Morteza Nasiri; Sara Adarvishi
Journal:  World J Diabetes       Date:  2015-02-15

6.  Treatment outcomes in diabetic patients with chronic limb-threatening ischemia.

Authors:  Patric Liang; Peter A Soden; Sara L Zettervall; Katie E Shean; Sarah E Deery; Raul J Guzman; Allen D Hamdan; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2018-03-22       Impact factor: 4.268

7.  Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes.

Authors:  Magnus Löndahl; Per Katzman; Anders Nilsson; Christer Hammarlund
Journal:  Diabetes Care       Date:  2010-05       Impact factor: 19.112

Review 8.  Cost of diabetic eye, renal and foot complications: a methodological review.

Authors:  Solène Schirr-Bonnans; Nadège Costa; Hélène Derumeaux-Burel; Jérémy Bos; Benoît Lepage; Valérie Garnault; Jacques Martini; Hélène Hanaire; Marie-Christine Turnin; Laurent Molinier
Journal:  Eur J Health Econ       Date:  2016-03-14

Review 9.  Epidemiology and economic impact of meticillin-resistant Staphylococcus aureus: review and analysis of the literature.

Authors:  Andrew F Shorr
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

Review 10.  Clinical outcome of diabetic foot ulcers treated with negative pressure wound therapy and the transition from acute care to home care.

Authors:  Stephanie C Wu; David G Armstrong
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.